• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗人群中糖尿病的患病率、知晓率、治疗率和控制率:四项国家横断面 STEPwise 监测调查的结果。

Prevalence, awareness, treatment and control of diabetes among Iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys.

机构信息

Department of Epidemiology, School of Public Health, Iran University of Medical Sciences (IUMS), Tehran, Iran.

National Institute of Health Research (NIHR), Tehran University of Medical Sciences, Tehran (TUMS), No 70, Bozorgmehr St. Vesale Shirazi St., Tehran, Iran.

出版信息

BMC Public Health. 2022 Jun 18;22(1):1216. doi: 10.1186/s12889-022-13627-6.

DOI:10.1186/s12889-022-13627-6
PMID:35717151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9206740/
Abstract

BACKGROUND

Diabetes as a leading cause of death imposes a heavy burden on health systems worldwide. This study investigated the trends in prevalence, awareness, treatment and control of diabetes among Iranian population aged 25 to 65 years over 12 years (2004-2016).

METHODS

Secondary data analysis was performed using data from a national population-based survey, STEPwise approach to surveillance (STEPS) for non-communicable diseases (NCDs) in four rounds (2004, 2007, 2011, 2016). The sample sizes were 89,404, 29,991, 12,103 and 30,541 individuals, respectively across the country in both rural and urban areas. Data were analyzed using descriptive statistics and a logistic regression model with odds ratio at a significance level of less than 5% with no adjustment for age and sex. Logistic regression was used to identify socio-demographic factors associated with the levels of awareness, treatment and control of diabetes mellitus.

RESULTS

The prevalence of diabetes in four rounds was 8.4, 9, 11.1 and 13.2%, respectively. Among people with diabetes, 53.5, 65.6, 70.5 and 82.2% were aware of their condition and 35.9, 42, 46 and 39.6% were treated for this condition, respectively. In four rounds of study, 14.5, 20.8, 20.4 and 18.5% of all diabetic patients had adequate glycemic control, respectively. In the multivariable logistic regression analysis, there was a significant relationship between female gender, age over 40, living in the urban area, being in the third wealth quintile and having health insurance with diabetes prevalence. Female participants were more likely to be aware of the disease. Older participants were more likely to receive treatment and had adequate glycemic control.

CONCLUSION

The prevalence of diabetes in Iran has been increasing and despite the great awareness of the disease, receiving treatment and effective control of the disease are suboptimal. While several national policies to improve diabetes screening and care have been passed in recent years, it seems large gaps remain in disease detection and treatment. It is suggested that more attention be paid to the treatment and control of diabetes by NCDs national policies to prevent the growing burden associated with the disease.

摘要

背景

糖尿病作为主要死因,给全球卫生系统带来了沉重负担。本研究旨在调查 12 年间(2004-2016 年)伊朗 25-65 岁人群糖尿病的患病率、知晓率、治疗率和控制率趋势。

方法

使用全国性人群为基础的调查(STEPwise 方法监测非传染性疾病(NCDs),简称 STEPS)的数据进行二次数据分析。共纳入 4 轮调查数据,研究人群分别为 89404、29991、12103 和 30541 人,样本覆盖全国城乡地区。采用描述性统计和 logistic 回归模型分析数据,比值比(OR)的显著性水平为 5%,未对年龄和性别进行调整。采用 logistic 回归分析识别与糖尿病知晓率、治疗率和控制率相关的社会人口学因素。

结果

四轮调查中糖尿病的患病率分别为 8.4%、9%、11.1%和 13.2%。在确诊糖尿病的患者中,分别有 53.5%、65.6%、70.5%和 82.2%知晓自身病情,分别有 35.9%、42%、46%和 39.6%接受了治疗。在四轮研究中,分别有 14.5%、20.8%、20.4%和 18.5%的糖尿病患者血糖控制达标。多变量 logistic 回归分析显示,女性、年龄>40 岁、居住在城区、处于第三财富五分位组和有医疗保险与糖尿病患病率相关。女性患者更有可能知晓自身疾病,年龄较大的患者更有可能接受治疗和血糖控制达标。

结论

伊朗的糖尿病患病率呈上升趋势,尽管患者对疾病的认知度较高,但治疗和有效控制率并不理想。近年来,伊朗通过了多项改善糖尿病筛查和管理的国家政策,但在疾病检出和治疗方面仍存在较大差距。建议国家非传染性疾病政策更加关注糖尿病的治疗和控制,以防止与该疾病相关的负担不断增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/9206740/bd65e0a4fbfb/12889_2022_13627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/9206740/bd65e0a4fbfb/12889_2022_13627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/9206740/bd65e0a4fbfb/12889_2022_13627_Fig1_HTML.jpg

相似文献

1
Prevalence, awareness, treatment and control of diabetes among Iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys.伊朗人群中糖尿病的患病率、知晓率、治疗率和控制率:四项国家横断面 STEPwise 监测调查的结果。
BMC Public Health. 2022 Jun 18;22(1):1216. doi: 10.1186/s12889-022-13627-6.
2
Socio-economic and demographic determinants of non-communicable diseases in Kenya: a secondary analysis of the Kenya stepwise survey.肯尼亚非传染性疾病的社会经济和人口决定因素:肯尼亚逐步调查的二次分析。
Pan Afr Med J. 2020 Dec 16;37:351. doi: 10.11604/pamj.2020.37.351.21167. eCollection 2020.
3
Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran.伊朗糖尿病患病率、诊断知晓率、治疗覆盖率和有效控制率的不平等:小区域估计分析。
BMC Endocr Disord. 2023 Jan 18;23(1):17. doi: 10.1186/s12902-023-01271-z.
4
Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study.伊朗人群中高血压、血脂异常和糖尿病的知晓率、治疗率和控制率:IHHP 研究。
East Mediterr Health J. 2009 Nov-Dec;15(6):1455-63.
5
Treatment-seeking behaviour among 15-49-year-olds with self-reported heart disease, cancer, chronic respiratory disease, and diabetes: a national cross-sectional study in India.15-49 岁有自我报告心脏病、癌症、慢性呼吸道疾病和糖尿病的患者的求治行为:印度的一项全国性横断面研究。
BMC Public Health. 2023 Nov 8;23(1):2197. doi: 10.1186/s12889-023-17123-3.
6
Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study.伊朗西南部的非传染性疾病:来自设拉子 PERSIAN 队列研究的特征和基线数据。
BMC Public Health. 2021 Dec 13;21(1):2275. doi: 10.1186/s12889-021-12326-y.
7
Prevalence, Awareness, Treatment, and Control of Hypertension and Diabetes: Results From Two State-Wide STEPS Survey in Punjab and Haryana, India.高血压和糖尿病的患病率、知晓率、治疗率和控制率:来自印度旁遮普邦和哈里亚纳邦的两项州级 STEPS 调查结果。
Front Public Health. 2022 Mar 21;10:768471. doi: 10.3389/fpubh.2022.768471. eCollection 2022.
8
Prevalence and Determinants of Severe Mental Disorders in Iran: Evidence from the National Survey of STEPs- 2016.伊朗严重精神障碍的患病率及决定因素:来自2016年全国STEP调查的证据
Arch Iran Med. 2022 Jul 1;25(7):460-472. doi: 10.34172/aim.2022.76.
9
Determinants of glycemic control: Phase 2 analysis from nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2018).血糖控制的决定因素:全国糖尿病预防和控制计划(NPPCD-2018)全国糖尿病报告的 2 期分析。
Prim Care Diabetes. 2020 Jun;14(3):222-231. doi: 10.1016/j.pcd.2019.07.002. Epub 2019 Aug 8.
10
Inequality in prevalence, awareness, treatment, and control of hypertension in Iran: the analysis of national households' data.伊朗高血压的患病率、知晓率、治疗率和控制率的不平等:来自全国家庭调查数据的分析。
BMC Public Health. 2022 Dec 14;22(1):2349. doi: 10.1186/s12889-022-14768-4.

引用本文的文献

1
Prevalence, awareness, treatment, and control of prediabetes and diabetes mellitus in older adults: findings from Iranian STEPS surveys (2016 and 2021).老年人糖尿病前期和糖尿病的患病率、知晓率、治疗率及控制率:伊朗STEPS调查(2016年和2021年)的结果
BMC Public Health. 2025 Aug 5;25(1):2658. doi: 10.1186/s12889-025-23654-8.
2
Economic Burden of Obesity in Iran University of Medical Sciences: A Cost Analysis Using the Cost of Illness Framework.伊朗医科大学肥胖症的经济负担:基于疾病成本框架的成本分析
Health Sci Rep. 2025 Jun 30;8(7):e70970. doi: 10.1002/hsr2.70970. eCollection 2025 Jul.
3
Association between diabetes phenotypes with hypertension and cardiovascular diseases, using single-sample confirmatory testing: a national study.

本文引用的文献

1
Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action.中东和北非地区2型糖尿病的流行病学:挑战与行动呼吁。
World J Diabetes. 2021 Sep 15;12(9):1401-1425. doi: 10.4239/wjd.v12.i9.1401.
2
Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study.伊朗成年人中糖尿病和糖尿病前期的全国患病率及相关危险因素:基于波斯队列研究的数据分析
Diabetes Ther. 2021 Nov;12(11):2921-2938. doi: 10.1007/s13300-021-01152-5. Epub 2021 Sep 30.
3
Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model.
使用单样本验证性检测探究糖尿病表型与高血压及心血管疾病之间的关联:一项全国性研究
Acta Diabetol. 2025 Apr 22. doi: 10.1007/s00592-025-02484-5.
4
Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review.伊朗2型糖尿病生活方式医学面临的挑战:综述
Am J Lifestyle Med. 2023 Apr 3;19(4):534-547. doi: 10.1177/15598276231167787. eCollection 2025 May-Jun.
5
Identifying the critical management aspects for diabetic patients A qualitative study.识别糖尿病患者的关键管理方面:一项定性研究
J Educ Health Promot. 2025 Jan 31;14:5. doi: 10.4103/jehp.jehp_1183_23. eCollection 2025.
6
How perceived risk of recurrence strengthens health management awareness in stroke patients: the chain mediating role of risk fear and health literacy.感知复发风险如何增强卒中患者的健康管理意识:风险恐惧和健康素养的链式中介作用
Front Public Health. 2025 Feb 20;13:1524492. doi: 10.3389/fpubh.2025.1524492. eCollection 2025.
7
Predicting preventive self-care behaviours among type 2 diabetes based on the health belief model in Bandar Abbas city: a cross-sectional study.基于健康信念模型预测阿巴斯港2型糖尿病患者的预防性自我护理行为:一项横断面研究
BMJ Open. 2025 Jan 25;15(1):e091420. doi: 10.1136/bmjopen-2024-091420.
8
Health indicators in the management of diabetes in Primary health care: Iran-package of Essential Non-communicable diseases (IraPEN) program.初级卫生保健中糖尿病管理的健康指标:伊朗基本非传染性疾病套餐(IraPEN)项目
J Diabetes Metab Disord. 2025 Jan 8;24(1):40. doi: 10.1007/s40200-024-01550-z. eCollection 2025 Jun.
9
Prevalence of cataracts in Iran based on the Persian eye cohort study.基于波斯眼队列研究的伊朗白内障患病率
Sci Rep. 2024 Dec 30;14(1):31812. doi: 10.1038/s41598-024-83080-5.
10
Availability and affordability of diabetes healthcare services associated with the frequency of diabetes-related complications.糖尿病医疗服务的可及性和可负担性与糖尿病相关并发症的发生频率相关。
BMC Health Serv Res. 2024 Dec 18;24(1):1586. doi: 10.1186/s12913-024-12065-x.
在中低收入国家增加对糖尿病及其相关心血管风险因素的诊断、治疗和控制的估计效果:一个微观模拟模型。
Lancet Glob Health. 2021 Nov;9(11):e1539-e1552. doi: 10.1016/S2214-109X(21)00340-5. Epub 2021 Sep 22.
4
Forgone care in patients with type 2 diabetes: a cross-sectional study.2 型糖尿病患者被忽视的医疗照护:一项横断面研究。
BMC Public Health. 2021 Aug 24;21(1):1588. doi: 10.1186/s12889-021-11639-2.
5
Dietary Management of Type 2 Diabetes in the MENA Region: A Review of the Evidence.中东和北非地区 2 型糖尿病的饮食管理:证据回顾。
Nutrients. 2021 Mar 24;13(4):1060. doi: 10.3390/nu13041060.
6
Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction; questioning the current diagnostic criteria.评估不同空腹血糖水平范围内血管疾病的归因风险,并评估抗糖尿病药物在降低风险方面的有效性;对当前的诊断标准提出质疑。
J Diabetes Metab Disord. 2020 Nov 16;19(2):1423-1430. doi: 10.1007/s40200-020-00663-5. eCollection 2020 Dec.
7
National trends in cardiovascular health metrics among Iranian adults using results of three cross-sectional STEPwise approaches to surveillance surveys.利用三种 STEPwise 监测调查的横断面研究结果,评估伊朗成年人心血管健康指标的国家趋势。
Sci Rep. 2021 Jan 8;11(1):58. doi: 10.1038/s41598-020-79322-x.
8
Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.全球、地区和国家 195 个国家和地区的糖尿病负担和趋势:1990 年至 2025 年的分析。
Sci Rep. 2020 Sep 8;10(1):14790. doi: 10.1038/s41598-020-71908-9.
9
Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran's Health System Context.糖尿病患者药物治疗的负担能力:伊朗卫生系统背景下基于情景的评估。
Int J Health Policy Manag. 2022 Apr 1;11(4):443-452. doi: 10.34172/ijhpm.2020.152.
10
Challenges of managing diabetes in Iran: meta-synthesis of qualitative studies.伊朗糖尿病管理面临的挑战:定性研究的综合分析。
BMC Health Serv Res. 2020 Jun 12;20(1):534. doi: 10.1186/s12913-020-05130-8.